UT Health San Antonio Multispecialty and Research Hospital says it’s the first in Texas to add a new non-opioid medication to ...

UT Health San Antonio Multispecialty and Research Hospital is the first hospital in Texas to approve a non-narcotic ...

Buy-and-hold investing is a time-tested strategy that rewards patience and discipline. By owning high-quality stocks for at ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $482.4, with a high estimate of $567.00 and a low estimate of $420.00. This current average ...

Nicolette Natale, D.O., whose areas of expertise include the treatment of substance abuse disorders. Courtesy Nicolette Natale, D.O. According to ...

“The phase 3 safety and efficacy across the three studies are impressive and demonstrate VX-548’s potential to change the paradigm of pain management ... painkiller Journavx, and a partnership ...

In today’s spine and pain management landscape, the only thing more overwhelming than the condition itself is the sheer ...

Researchers developed a novel ultrasonic implant that shows promise for personalized, efficient, and minimally invasive ...

Opioid initiation rates were higher in individuals with Parkinson’s disease, starting up to 3 years before diagnosis and ...